Adiponectin modulates ventral tegmental area dopamine neuron activity and anxiety-related behavior through AdipoR1
10.1038/s41380-018-0102-9 · doi-reference
Modulation of the mesolimbic dopamine system by leptin
10.1016/j.brainres.2010.04.028 · doi-reference
Mood disorders: A potential link between ghrelin and leptin on human body
10.5493/wjem.v5.i2.103 · doi-reference
Striatal dopamine synthesis capacity and its association with negative symptoms upon resolution of positive symptoms in first-episode schizophrenia and delusional disorder
10.1007/s00213-022-06088-7 · doi-reference
Dopamine neurons modulate neural encoding and expression of depression-related behaviour
10.1038/nature11740 · doi-reference
Bidirectional prospective associations of metabolic syndrome components with depression, anxiety, and antidepressant use
10.1002/da.22512 · doi-reference
Leptin receptor signaling in POMC neurons is required for normal body weight homeostasis
10.1016/j.neuron.2004.06.004 · doi-reference
Leptin action via neurotensin neurons controls orexin, the mesolimbic dopamine system and energy balance
10.1016/j.cmet.2011.06.016 · doi-reference
Hyperleptinemia contributes to antipsychotic drug-associated obesity and metabolic disorders
10.1126/scitranslmed.ade8460 · doi-reference
Effects of the second-generation antipsychotic drugs aripiprazole and olanzapine on human adipocyte differentiation
10.1016/j.mce.2022.111828 · doi-reference
The cellular and molecular bases of leptin and ghrelin resistance in obesity
10.1038/nrendo.2016.222 · doi-reference
Changes in insulin resistance following bariatric surgery and the adipoinsular axis: role of the adipocytokines, leptin, adiponectin and resistin
10.1381/0960892053923789 · doi-reference
Focus on prolactin as a metabolic hormone
10.1016/j.tem.2006.02.005 · doi-reference
Antipsychotic-induced hyperprolactinemia
10.1592/phco.29.1.64 · doi-reference
Early-onset bipolar disorder: characteristics and outcomes in the clinic
10.1089/cap.2017.0058 · doi-reference
Towards an immuno-precipitated neurodevelopmental animal model of schizophrenia
10.1016/j.neubiorev.2004.10.012 · doi-reference
Olanzapine reduced brown adipose tissue thermogenesis and locomotor activity in female rats
10.1016/j.pnpbp.2014.02.003 · doi-reference
Risperidone-induced weight gain and reduced locomotor activity in juvenile female rats: The role of histaminergic and NPY pathways
10.1016/j.phrs.2015.03.004 · doi-reference
The dynamical association between physical activity and affect in the daily life of individuals with ADHD
10.1016/j.euroneuro.2022.01.110 · doi-reference
Altered circadian rhythms in a mouse model of neurodevelopmental disorders based on prenatal maternal immune activation
10.1016/j.bbi.2020.12.030 · doi-reference
Olanzapine, but not aripiprazole, weight-independently elevates serum triglycerides and activates lipogenic gene expression in female rats
10.1017/s1461145711001271 · doi-reference
Effects of walkability on physical activity and obesity: a prospective observational study protocol
10.1136/bmjopen-2019-034882 · doi-reference
Physical activity and training against obesity
10.1556/oh.2010.28802 · doi-reference
Resistance exercise, disability, and pain catastrophizing in obese adults with back pain
10.1249/mss.0000000000000294 · doi-reference
Physical activity and maternal obesity: cardiovascular adaptations, exercise recommendations, and pregnancy outcomes
10.1111/nure.12064 · doi-reference
Improved social interaction, recognition and working memory with cannabidiol treatment in a prenatal infection (poly I:C) rat model
10.1038/npp.2017.40 · doi-reference
Adiposity in schizophrenia: A systematic review and meta-analysis
10.1111/acps.13365 · doi-reference
Visceral obesity in normal-weight patients suffering from chronic schizophrenia
10.1186/1471-244x-14-35 · doi-reference
Atypical antipsychotics and metabolic syndrome: from molecular mechanisms to clinical differences
10.3390/ph14030238 · doi-reference
Priming of metabolic dysfunctions by prenatal immune activation in mice: relevance to schizophrenia
10.1093/schbul/sbr178 · doi-reference
The sex-dependent impact of chronic clozapine and haloperidol treatment on characteristics of the metabolic syndrome in a rat model
10.1055/s-0032-1321907 · doi-reference
Amisulpride, aripiprazole, and olanzapine in patients with schizophrenia-spectrum disorders (BeSt InTro): a pragmatic, rater-blind, semi-randomised trial
10.1016/s2215-0366(20)30341-2 · doi-reference
Intrinsic and antipsychotic drug-induced metabolic dysfunction in schizophrenia
10.3389/fnins.2017.00432 · doi-reference
Identification and treatment of individuals with childhood-onset and early-onset schizophrenia
10.1016/j.euroneuro.2024.02.005 · doi-reference
Timing of maternal immune activation and sex influence schizophrenia-relevant cognitive constructs and neuregulin and GABAergic pathways
10.1016/j.bbi.2021.11.006 · doi-reference
Olanzapine modulate lipid metabolism and adipose tissue accumulation via hepatic muscarinic M3 receptor-mediated alk-related signaling
10.3390/biomedicines12071403 · doi-reference
Epigenetic histone methylation of PPARgamma and CPT1A signaling contributes to betahistine preventing olanzapine-induced dyslipidemia
10.3390/ijms24119143 · doi-reference
Maternal immune activation causes social behavior deficits and hypomyelination in male rat offspring with an autism-like microbiota profile
10.3390/brainsci11081085 · doi-reference
Sex and gender bias in the experimental neurosciences: the case of the maternal immune activation model
10.1038/s41398-019-0423-8 · doi-reference
A comprehensive approach to modeling maternal immune activation in rodents
10.3389/fnins.2022.1071976 · doi-reference
